- Capsule
- Strengths: 250,500,750 mg (generics available)
- Tablet
- Strengths: 250,500 mg (generics available)
- Oral Suspension
- Strengths: 125,250 mg/5ml (generics available)
- Dosing
-
Higher Dose (GFR >60 ml/min)
- Indications
- Pneumonia
- Genitourinary Infection
- Skin and Soft Tissue Infection
- Dose
- Adults (age >15 years): 250-500 mg orally four times daily (max 4 g/day)
- Children: 25-50 mg/kg/day (max 100 mg/kg/day) divided four times daily
- Dosing
-
Lower Dose (GFR >60 ml/min)
- Indications
- Simple Urinary Tract Infection (treat for 5-7 days)
- Streptococcal Pharyngitis (treat for 10 days)
- Dose
- Adults (age >15 years): 500 mg orally twice daily
- Children: 25-50 mg/kg/day (max 100 mg/kg/day) divided twice daily
-
CrCl 30-60 ml/min
- Adults: 250 mg orally 3-4 times daily (maximum 1000 mg/day)
-
CrCl 15-30 ml/min
- Adults: 250 mg orally 2-3 times daily (maximum 750 mg/day)
-
CrCl <15 ml/min
- Adults: 250 mg orally daily (take a second dose as needed after Dialysis)
- Pregnancy Category B (All Trimesters)
- Safe in Lactation
- Absorption: Not affected by meals
- Peak Activity: >1 hours
- Primary Elimination: Renal
- (2012) Presc Lett, Resource #280706, Comparison of Cephalosporins
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
loading